Back | Next |
home / stock / apre / apre message board
Subject | By | Source | When |
---|---|---|---|
CASH ON HAND $77 MILLION | Jimmy Quick | investorshub | 06/23/2021 2:23:41 PM |
Overview We are a clinical-stage biopharmaceutical company focused on | Jimmy Quick | investorshub | 06/21/2021 7:54:37 PM |
I know this isn't a NASDAQ message board. | Jimmy Quick | investorshub | 06/18/2021 5:15:08 PM |
Totally agree, I have been loading up at | Jimmy Quick | investorshub | 06/17/2021 7:18:32 PM |
Pump and dump pos imo?? | Roadtojourney | investorshub | 06/16/2021 5:31:20 PM |
sold some $APRE on the pop today. | NATURES WAY | investorshub | 06/11/2021 4:24:51 PM |
loaded shares of apre today. Seems to be | NATURES WAY | investorshub | 05/07/2021 2:21:38 AM |
Got my order in at $20+. | Natureboy1 | investorshub | 04/08/2021 1:12:22 PM |
$APRE is extemely undervalued chart shows the significant | lukin4winners | investorshub | 02/11/2021 2:54:31 PM |
ready to fill that huge gap. | aristotelisonassis | investorshub | 02/10/2021 8:44:13 PM |
I agree. This stock is demanding attention and | RockStarInvestor | investorshub | 01/23/2021 2:47:47 PM |
I'm in @ 5.69 looks good from here | toytundra | investorshub | 01/22/2021 5:33:00 PM |
$APRE Chart and indicators looks ready for a | aristotelisonassis | investorshub | 01/21/2021 12:56:43 PM |
Jan 28th marks the end of the waiting | RockStarInvestor | investorshub | 01/19/2021 5:22:35 PM |
Jan 28th marks the end of the waiting | RockStarInvestor | investorshub | 01/19/2021 5:21:40 PM |
Another buying opportunity has appeared. Looking forward to | RockStarInvestor | investorshub | 01/15/2021 6:22:52 PM |
Welcome! There is alot of information on the | RockStarInvestor | investorshub | 01/15/2021 6:14:19 PM |
Hello just found this company on another bio | Harbor6460 | investorshub | 01/15/2021 2:14:23 AM |
After a great premarket open the profit takers | RockStarInvestor | investorshub | 01/13/2021 6:03:44 PM |
It's good to know they are still a | RockStarInvestor | investorshub | 01/13/2021 2:29:20 PM |
News, Short Squeeze, Breakout and More Instantly...
Aprea Therapeutics Inc. Company Name:
APRE Stock Symbol:
NYSE Market:
2024-05-16 06:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
U.S. FDA cleared IND for APR-1051, a highly selective and potentially best-in-class oral WEE1 inhibitor; Company plans to initiate Phase 1 ACESOT-1051 clinical trial in June 2024 First-in-class macrocyclic ATR inhibitor, ATRN-119, on track to complete dose escalation in ABOYA-119 c...
DOYLESTOWN, Pa., May 13, 2024 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (NASDAQ:APRE) ("Aprea" or the "Company"), a clinical stage biopharmac...